161 related articles for article (PubMed ID: 11352401)
21. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
Smith DR; Ji CY; Goh HS
Br J Cancer; 1996 Jul; 74(2):216-23. PubMed ID: 8688324
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of oncoprotein p53, rasp21 and p185 in carcinomas and polyps of the large intestine].
Wang J; Ni CR
Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):97-9. PubMed ID: 7915970
[TBL] [Abstract][Full Text] [Related]
24. Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence.
Yao T; Kajiwara M; Kouzuki T; Iwashita A; Tsuneyoshi M
Pathol Int; 1999 May; 49(5):374-82. PubMed ID: 10417679
[TBL] [Abstract][Full Text] [Related]
25. Over-expression of p53 nuclear oncoprotein in colorectal adenomas.
Pignatelli M; Stamp GW; Kafiri G; Lane D; Bodmer WF
Int J Cancer; 1992 Mar; 50(5):683-8. PubMed ID: 1347513
[TBL] [Abstract][Full Text] [Related]
26. p53 immunoreactive stain and early colorectal adenocarcinomas.
Hirota S; Kudo S; Hosobe S; Kobayashi T; Himori M; Ikeda M; Takemoto Y; Nomoto M; Aoyagi Y; Asakura H
Eur J Cancer; 1995 Dec; 31A(13-14):2220-2. PubMed ID: 8652246
[TBL] [Abstract][Full Text] [Related]
27. Discordance of p53 mutations of synchronous colorectal carcinomas.
Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
[TBL] [Abstract][Full Text] [Related]
28. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
29. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC
Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966
[TBL] [Abstract][Full Text] [Related]
30. [Apoptosis and expression of its regulating genes in adenoma and adenocarcinoma of large intestine].
Sun B; Zhang N; Zhao X
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):137-40. PubMed ID: 10072852
[TBL] [Abstract][Full Text] [Related]
31. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
32. p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. An immunohistochemical examination on paraffin sections.
Nielsen AL; Nyholm HC
Am J Clin Pathol; 1994 Jul; 102(1):76-9. PubMed ID: 7913577
[TBL] [Abstract][Full Text] [Related]
33. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Nordenskjöld B
Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
[TBL] [Abstract][Full Text] [Related]
35. p53 protein expression in transitional mucosa and adenocarcinomas of the colorectum.
Connelly JH; Bruner JM; Robey-Cafferty SS; Sahin A
Mod Pathol; 1992 Sep; 5(5):537-9. PubMed ID: 1344817
[TBL] [Abstract][Full Text] [Related]
36. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
37. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma.
Auer GU; Heselmeyer KM; Steinbeck RG; Munck-Wikland E; Zetterberg AD
Virchows Arch; 1994; 424(4):343-7. PubMed ID: 8205349
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).
Baretton GB; Vogt M; Müller C; Diebold J; Schneiderbanger K; Schmidt M; Löhrs U
Scand J Gastroenterol; 1996 May; 31(5):481-9. PubMed ID: 8734346
[TBL] [Abstract][Full Text] [Related]
39. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
40. p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.
Dalifard I; Daver A; Goussard J; Lorimier G; Gosse-Brun S; Lortholary A; Larra F
Int J Mol Med; 1998 May; 1(5):855-61. PubMed ID: 9852307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
